EIF2A Antikörper (C-Term)
Kurzübersicht für EIF2A Antikörper (C-Term) (ABIN630028)
Target
Alle EIF2A Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Spezifität
- EIF2 A antibody was raised against the C terminal of EIF2
-
Aufreinigung
- Purified
-
Immunogen
- EIF2 A antibody was raised using the C terminal of EIF2 corresponding to a region with amino acids DKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQ
-
-
-
-
Applikationshinweise
-
WB: 2.5 µg/mL, IHC: 4-8 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
EIF2A Blocking Peptide, (ABIN937417), is also available for use as a blocking control in assays to test for specificity of this EIF2A antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of EIF0 antibody in PBS
-
Konzentration
- Lot specific
-
Buffer
- PBS
-
Handhabung
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- EIF2A (Eukaryotic Translation Initiation Factor 2A, 65kDa (EIF2A))
-
Andere Bezeichnung
- EIF2A
-
Hintergrund
- EIF2A is a 65 kDa protein that catalyzes the formation of puromycin-sensitive 80S preinitiation complexes.
-
Molekulargewicht
- 64 kDa (MW of target protein)
-
Pathways
- Ribonucleoprotein Complex Subunit Organization, ER-Nucleus Signaling, Hepatitis C, Methionine Biosynthetic Process, Ribosome Assembly
Target
-